Berapa harga Xuanzhubio-b (2575)

Harga Xuanzhubio-b (2575) adalah $1.35

Apa kapitalisasi pasar Xuanzhubio-b (2575)

Kapitalisasi pasar Xuanzhubio-b (2575) adalah $700.36M

Xuanzhubio-b (2575) Dividen

Xuanzhu Biopharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the research, production, and commercialization of both small-molecule chemical compounds and large-molecule biopharmaceuticals. The company's primary drug candidates include Core- KBP-3571, developed for treating duodenal ulcers; XZP-3287, a CDK4/6 inhibitor aimed at advanced HR+/HER2 breast cancer; and XZP-3621, intended as a first-line therapy for patients suffering from anaplastic lymphoma kinase-positive (ALK+) advanced non-small-cell lung cancer. Its development pipeline further encompasses KM501, a pioneering HER2/HER2 bispecific antibody drug conjugate currently in Phase I clinical trials, alongside KM602, another anti-tumor agent also undergoing Phase I evaluation. Other investigational assets include XZP-7797, a selective and brain-penetrating poly ADP-ribose polymerase 1 (PARP1) inhibitor; XZP-6924, which targets ubiquitin-specific protease 1 (USP1); XZB-0004, an oral small molecule anexelekto inhibitor; and XZP-6877, a DNA-dependent protein kinase inhibitor. The portfolio also features NG-350A, a next-generation oncolytic viral therapy; XZP-5610, a non-steroidal farnesoid X receptor; and XZP-6019, a first-in-class ketohexokinase (KHK) inhibitor. Founded in 2008 and headquartered in Beijing, China, Xuanzhu Biopharmaceutical Co., Ltd. operates as a subsidiary of Sihuan Pharm.

Tahun	Dividen (disesuaikan dengan stock split)	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen (disesuaikan dengan stock split)

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Tahun	Dividen	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Dividen

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Jumlah pembayaran dividen	Negara
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.00%	IN

Perusahaan

Jumlah pembayaran dividen

Negara